We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current XTNT market cap is 66.25M. The company's latest EPS is USD -0.1183 and P/E is -4.06.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 28.11M | 27.87M | 29.94M | 27.94M | 31.51M |
| Operating Income | -3.81M | -3.47M | -2.95M | -3.78M | -1.88M |
| Net Income | -4.3M | -4.4M | -3.86M | -5.02M | -3.17M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 53.34M | 55.26M | 57.97M | 91.3M | 117.27M |
| Operating Income | -751k | -3.85M | -6.76M | -10.16M | -12.07M |
| Net Income | -7.02M | -4.85M | -8.49M | 660k | -16.45M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 92.61M | 93.93M | 95.58M | 98.88M | 93.84M |
| Total Liabilities | 41.26M | 46.25M | 50.57M | 53.16M | 50.87M |
| Total Equity | 51.35M | 47.68M | 45.01M | 45.73M | 42.96M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 41.47M | 54.69M | 60.23M | 92.61M | 93.84M |
| Total Liabilities | 26.95M | 23.81M | 26.06M | 41.26M | 50.87M |
| Total Equity | 14.51M | 30.88M | 34.17M | 51.35M | 42.96M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -9.52M | -5.76M | -10.84M | -12.56M | -11.9M |
| Investing | -24.78M | -674k | -1.15M | -3.16M | -3.73M |
| Financing | 19.69M | 5.18M | 11.61M | 16.93M | 16.07M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -731k | 439k | -5.34M | -9.52M | -11.9M |
| Investing | -1.3M | -1.89M | -1.56M | -24.78M | -3.73M |
| Financing | -861k | 17.5M | 9.02M | 19.69M | 16.07M |
| Market Cap | 66.25M |
| Price to Earnings Ratio | -4.06 |
| Price to Sales Ratio | 0.57 |
| Price to Cash Ratio | 10.76 |
| Price to Book Ratio | 1.55 |
| Dividend Yield | - |
| Shares Outstanding | 139.07M |
| Average Volume (1 week) | 25.74k |
| Average Volume (1 Month) | 132.37k |
| 52 Week Change | -58.57% |
| 52 Week High | 1.24 |
| 52 Week Low | 0.331 |
| Spread (Intraday) | 0.12 (21.43%) |
| Company Name | Xtant Medical Holdings Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://xtantmedical.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
